Cannabinoid Receptors CB1 and CB2 Form Functional Heteromers in Brain

被引:180
|
作者
Callen, Lucia [1 ,2 ]
Moreno, Estefania [1 ,2 ]
Barroso-Chinea, Pedro [2 ,3 ]
Moreno-Delgado, David [1 ,2 ]
Cortes, Antoni [1 ,2 ]
Mallol, Josefa [1 ,2 ]
Casado, Vicent [1 ,2 ]
Luis Lanciego, Jose [2 ,3 ]
Franco, Rafael [3 ]
Lluis, Carmen [1 ,2 ]
Canela, Enric I. [1 ,2 ]
McCormick, Peter J. [1 ,2 ]
机构
[1] Univ Barcelona, Fac Biol, Dept Biochem & Mol Biol, E-08028 Barcelona, Spain
[2] Univ Navarra, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Pamplona 31008, Spain
[3] Univ Navarra, Ctr Invest Med Aplicada, Pamplona 31008, Spain
关键词
RAT PINEAL-GLAND; ARYLALKYLAMINE N-ACETYLTRANSFERASE; NEURAL PROGENITOR PROLIFERATION; PROXIMITY LIGATION ASSAY; ENDOCANNABINOID SYSTEM; ADENOSINE A(2A); RETINOIC ACID; HUMAN NEUROBLASTOMA; NUCLEUS-ACCUMBENS; MICROGLIAL CELLS;
D O I
10.1074/jbc.M111.335273
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Exploring the role of cannabinoid CB2 receptors in the brain, we present evidence of CB2 receptor molecular and functional interaction with cannabinoid CB1 receptors. Using biophysical and biochemical approaches, we discovered that CB2 receptors can form heteromers with CB1 receptors in transfected neuronal cells and in rat brain pineal gland, nucleus accumbens, and globus pallidus. Within CB1-CB2 receptor heteromers expressed in a neuronal cell model, agonist co-activation of CB1 and CB2 receptors resulted in a negative cross-talk in Akt phosphorylation and neurite outgrowth. Moreover, one specific characteristic of CB1-CB2 receptor heteromers consists of both the ability of CB1 receptor antagonists to block the effect of CB2 receptor agonists and, conversely, the ability of CB2 receptor antagonists to block the effect of CB1 receptor agonists, showing a bidirectional cross-antagonism phenomenon. Taken together, these data illuminate the mechanism by which CB2 receptors can negatively modulate CB1 receptor function.
引用
收藏
页码:20851 / 20865
页数:15
相关论文
共 50 条
  • [31] Recent Development of CB2 Selective and Peripheral CB1/CB2 Cannabinoid Receptor Ligands
    Nevalainen, Tapio
    CURRENT MEDICINAL CHEMISTRY, 2014, 21 (02) : 187 - 203
  • [32] Control of spasticity in a multiple sclerosis model is mediated by CB1, not CB2, cannabinoid receptors
    Pryce, G.
    Baker, D.
    BRITISH JOURNAL OF PHARMACOLOGY, 2007, 150 (04) : 519 - 525
  • [33] Allosteric modulators targeting cannabinoid cb1 and cb2 receptors: implications for drug discovery
    Gado, Francesca
    Meini, Serena
    Bertini, Simone
    Digiacomo, Maria
    Macchia, Marco
    Manera, Clementina
    FUTURE MEDICINAL CHEMISTRY, 2019, 11 (15) : 2019 - 2037
  • [34] Heteromers Formed by GPR55 and Either Cannabinoid CB1 or CB2 Receptors Are Upregulated in the Prefrontal Cortex of Multiple Sclerosis Patients
    Menendez-Perez, Carlota
    Rivas-Santisteban, Rafael
    del Valle, Eva
    Tolivia, Jorge
    Navarro, Ana
    Franco, Rafael
    Martinez-Pinilla, Eva
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (08)
  • [35] Homology models of the cannabinoid CB1 and CB2 receptors.: A docking analysis study
    Montero, C
    Campillo, NE
    Goya, P
    Páez, JA
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2005, 40 (01) : 75 - 83
  • [36] COMPARISON OF THE PHARMACOLOGY AND SIGNAL-TRANSDUCTION OF THE HUMAN CANNABINOID CB1 AND CB2 RECEPTORS
    FELDER, CC
    JOYCE, KE
    BRILEY, EM
    MANSOURI, J
    MACKIE, K
    BLOND, O
    LAI, Y
    MA, AL
    MITCHELL, RL
    MOLECULAR PHARMACOLOGY, 1995, 48 (03) : 443 - 450
  • [37] Reduced Noradrenergic Signaling in the Spleen Capsule in the Absence of CB1 and CB2 Cannabinoid Receptors
    Simkins, Tyrell J.
    Fried, David
    Parikh, Kevin
    Galligan, James J.
    Goudreau, John L.
    Lookingland, Keith J.
    Kaplan, Barbara L. F.
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2016, 11 (04) : 669 - 679
  • [38] Reduced Noradrenergic Signaling in the Spleen Capsule in the Absence of CB1 and CB2 Cannabinoid Receptors
    Tyrell J. Simkins
    David Fried
    Kevin Parikh
    James J. Galligan
    John L. Goudreau
    Keith J. Lookingland
    Barbara L. F. Kaplan
    Journal of Neuroimmune Pharmacology, 2016, 11 : 669 - 679
  • [39] Effects of Cocaine Self-Administration and Its Extinction on the Rat Brain Cannabinoid CB1 and CB2 Receptors
    Beata Bystrowska
    Małgorzata Frankowska
    Irena Smaga
    Lucyna Pomierny-Chamioło
    Małgorzata Filip
    Neurotoxicity Research, 2018, 34 : 547 - 558
  • [40] Effects of Cocaine Self-Administration and Its Extinction on the Rat Brain Cannabinoid CB1 and CB2 Receptors
    Bystrowska, Beata
    Frankowska, Malgorzata
    Smaga, Irena
    Pomierny-Chamiolo, Lucyna
    Filip, Malgorzata
    NEUROTOXICITY RESEARCH, 2018, 34 (03) : 547 - 558